Late Phase Clinical Trials

The Context
Late phase clinical trials are all about a successful transition from development to commercialisation and it is important to understand that they are conducted for various reasons that differ to those of earlier stage clinical trials. In some cases, it will be for providing a strong confirmation of your product’s pre-approval study data on larger patient groups; in other case, it will be for the exploration of new indications by studying different patient populations.

Our Solution
Different goals mean a different approach and we always keep in mind that your clients are our clients too. In this context, we will strive to develop a fruitful relationship with investigators and to promote the image of your company and compounds as if they were our own. We know you worked hard to build and maintain sponsor/site relationships and we will make sure we never compromise them. Our monitors will simply be an extension of your own field staff.
At every stage of the project we will give you the visibility and transparency you need to check the progress of your research without involving you in tedious micromanagement and unnecessary work.

Our Capabilities
Project Management  Medical Writing / Medical Monitoring
Site Identification and Qualification / Regulatory Affairs   
Clinical Monitoring /Data Management and Biostatistics
Pharmacovigilance / Quality Assurance

Call us to find out how our Phase II and III Clinical Trials Solutions can work for you

Why Africa

Africa offers an increasing number of experienced researchers through networks of excellence implemented ...

Read more

Partners

At Pharmalys we believe in the value of partnership, sharing knowledge and establishing synergies in order to develop innovative solutions ...

Read more

Become an Investigator

You can make a difference to a noble cause by getting involved in health related studies

Read more

Contact

Pharmalys Ltd UK
Tel: +44 208 0909 620

Pharmalys SARL Senegal
Tel: +221 33 825 42 43

Read more
Go to top